Related references
Note: Only part of the references are listed.Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity
Stefano Caruso et al.
HEPATOLOGY (2021)
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
Kim A. Reiss et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Recent progress in TGF-β inhibitors for cancer therapy
Cheng-Yi Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma
Sandra J. Casak et al.
CLINICAL CANCER RESEARCH (2021)
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy
Jitang Chen et al.
THERANOSTICS (2021)
Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer
Daniel Caballero-Diaz et al.
JOURNAL OF HEPATOLOGY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2020)
Advances in molecular classification and precision oncology in hepatocellular carcinoma
Sandra Rebouissou et al.
JOURNAL OF HEPATOLOGY (2020)
Sequential systemic treatment in patients with hepatocellular carcinoma
Martha M. Kirstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Safety and Tolerability of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Asian Patients with Pretreated Recurrent or Refractory Gastric Cancer
Yoon-Koo Kang et al.
CLINICAL CANCER RESEARCH (2020)
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli et al.
PLOS ONE (2020)
Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival
SiZhe Yu et al.
PLOS ONE (2020)
Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
Constance J. Martin et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Sequencing of systemic treatment for hepatocellular carcinoma: Second line competitors
Federico Pinero et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
Luis Paz-Ares et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancer
Changhoon Yoo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety-Assessment Cohort
Toshihiko Doi et al.
ONCOLOGIST (2020)
Hepatic Stellate Cells and Hepatocarcinogenesis
Anna E. Barry et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Min Zhang et al.
JOURNAL OF HEPATOLOGY (2020)
Transforming Growth Factor-β Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts
Xueke Shi et al.
BIOMOLECULES (2020)
TGF-β2 is a Prognostic Biomarker Correlated with Immune Cell Infiltration in Colorectal Cancer A STROBE-compliant article
Yifeng Tu et al.
MEDICINE (2020)
Recent Advances in the Development of TGF-β Signaling Inhibitors for Anticancer Therapy
Ho-Jae Lee
JOURNAL OF CANCER PREVENTION (2020)
Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade
Rita Greco et al.
ONCOIMMUNOLOGY (2020)
AVID200, FIRST-IN-CLASS TGF-BETA1 AND BETA3 SELECTIVE INHIBITOR: RESULTS OF A PHASE 1 MONOTHERAPY DOSE ESCALATION STUDY IN SOLID TUMORS AND EVIDENCE OF TARGET ENGAGEMENT IN PATIENTSy
Timothy Yap et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A phase 1b study of transforming growth factor-beta receptor I inhibitor galunisertib in combination with sorafenib in Japanese patients with unresectable hepatocellular carcinoma
Masafumi Ikeda et al.
INVESTIGATIONAL NEW DRUGS (2019)
CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma
Long-Zi Liu et al.
HEPATOLOGY (2019)
Specificity, versatility, and control of TGF-β family signaling
Rik Derynck et al.
SCIENCE SIGNALING (2019)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by -TGF antibody to promote durable rejection and immunity in squamous cell carcinomas
E. Dodagatta-Marri et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Induction of tolerogenic dendritic cells by activated TGF-/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells
Ming Zhong et al.
BMC CANCER (2019)
Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma
Sandrine Faivre et al.
LIVER INTERNATIONAL (2019)
LXRα limits TGFβ-dependent hepatocellular carcinoma associated fibroblast differentiation
Anita Moren et al.
ONCOGENESIS (2019)
Insights into the success and failure of systemic therapy for hepatocellular carcinoma
Jordi Bruix et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
Jian Chen et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Ela Elyada et al.
CANCER DISCOVERY (2019)
A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
R. K. Kelley et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
TGF-β signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond syndrome
Cailin E. Joyce et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
T Yau et al.
ANNALS OF ONCOLOGY (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives
Francesco Dituri et al.
SEMINARS IN LIVER DISEASE (2019)
CD4+ CD25+ regulatory T cells promote hepatocellular carcinoma invasion via TGF-β1-induced epithelial-mesenchymal transition
Chunying Shi et al.
ONCOTARGETS AND THERAPY (2019)
Systematic review with meta-analysis: the critical role of dermatological events in patients with hepatocellular carcinoma treated with sorafenib
Alvaro Diaz-Gonzalez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer
Brooke A. Pereira et al.
TRENDS IN CANCER (2019)
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway
Jian Chen et al.
GASTROENTEROLOGY (2018)
Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells
Jun Arai et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Daniele V. F. Tauriello et al.
NATURE (2018)
Contextual determinants of TGFβ action in development, immunity and cancer
Charles J. David et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
Yan Lan et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Galunisertib suppresses the staminal phenotype in hepatocellular carcinoma by modulating CD44 expression
Bhavna Rani et al.
CELL DEATH & DISEASE (2018)
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGF beta enhance the efficacy of cancer immunotherapy
Rajani Ravi et al.
NATURE COMMUNICATIONS (2018)
CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128
Mohamed Badawi et al.
Oncotarget (2018)
IL-15 Overcomes Hepatocellular Carcinoma-Induced NK Cell Dysfunction
Nicholas J. W. Easom et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Rikke B. Holmgaard et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Neutrophils Promote Amphiregulin Production in Intestinal Epithelial Cells through TGF-β and Contribute to Intestinal Homeostasis
Feidi Chen et al.
JOURNAL OF IMMUNOLOGY (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis
Isabel Fabregat et al.
FRONTIERS IN ONCOLOGY (2018)
Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells
Naoki Takasaka et al.
JCI INSIGHT (2018)
TGFβ Signaling Confers Sorafenib Resistance via Induction of Multiple RTKs in Hepatocellular Carcinoma Cells
Nathan Ungerleider et al.
MOLECULAR CARCINOGENESIS (2017)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
iNKT Cells Orchestrate a Switch from Inflammation to Resolution of Sterile Liver Injury
Pei Xiong Liew et al.
IMMUNITY (2017)
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Daniel Ohlund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8
Julie Stockis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Transforming Growth Factor-β Receptors and Smads: Regulatory Complexity and Functional Versatility
Erine H. Budi et al.
TRENDS IN CELL BIOLOGY (2017)
NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC
Yuan Cao et al.
CELL DEATH & DISEASE (2017)
A phase 1 study of anti-TGFβ receptor type-II monoclonal antibody LY3022859 in patients with advanced solid tumors
Anthony W. Tolcher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Transforming growth factor-β-induced plasticity causes a migratory sternness phenotype in hepatocellular carcinoma
Andrea Malfettone et al.
CANCER LETTERS (2017)
The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib
Fernanda Branco et al.
ANNALS OF HEPATOLOGY (2017)
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver
Monika Rau et al.
JOURNAL OF IMMUNOLOGY (2016)
Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1
Guo-Cai Li et al.
ONCOLOGY LETTERS (2016)
Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma
Jine Yang et al.
CANCER LETTERS (2016)
Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways
Jiao Liu et al.
CANCER LETTERS (2016)
Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein
Spencer Ng et al.
CANCER RESEARCH (2016)
The role of integrins in TGFβ activation in the tumour stroma
Zareen Khan et al.
CELL AND TISSUE RESEARCH (2016)
The rationale for targeting TGF-β in chronic liver diseases
Gianluigi Giannelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
TGF-β signalling and liver disease
Isabel Fabregat et al.
FEBS JOURNAL (2016)
Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis
Sihua Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
The Discovery and Early Days of TGF-β: A Historical Perspective
Harold L. Moses et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
Benjamin V. Park et al.
CANCER DISCOVERY (2016)
A novel highly potent trivalent TGF-β receptor trap inhibits early-stage tumorigenesis and tumor cell invasion in murine Pten-deficient prostate glands
Tai Qin et al.
ONCOTARGET (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC
Andrew Gabrielson et al.
CANCER IMMUNOLOGY RESEARCH (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
TGF-β Regulates Hepatocellular Carcinoma Progression by Inducing Treg Cell Polarization
Yinan Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma
Teng Feng et al.
CLINICAL SCIENCE (2015)
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
Maria Serova et al.
ONCOTARGET (2015)
TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling
Sang-A Park et al.
SCIENTIFIC REPORTS (2015)
Critical role of tumor microenvironment in shaping NK cell functions: implication of hypoxic stress
Meriem Hasmim et al.
FRONTIERS IN IMMUNOLOGY (2015)
Immunological hallmarks of stromal cells in the tumour microenvironment
Shannon J. Turley et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Transforming Growth Factor Beta Signaling in Hepatocytes Participates in Steatohepatitis Through Regulation of Cell Death and Lipid Metabolism in Mice
Ling Yang et al.
HEPATOLOGY (2014)
TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells
Antonella Carambia et al.
JOURNAL OF HEPATOLOGY (2014)
Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2014)
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
John C. Morris et al.
PLOS ONE (2014)
Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells
Fei Jiang et al.
TOXICOLOGY LETTERS (2014)
Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17
J. Moreno-Caceres et al.
CELL DEATH & DISEASE (2014)
Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling
Ze-yang Ding et al.
CELLULAR SIGNALLING (2013)
Unchaining the beast; insights from structural and evolutionary studies on TGFβ secretion, sequestration, and activation
Ian B. Robertson et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Overactivation of the TGF-β Pathway Confers a Mesenchymal-Like Phenotype and CXCR4-Dependent Migratory Properties to Liver Tumor Cells
Esther Bertran et al.
HEPATOLOGY (2013)
Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions
Yan Wu et al.
HEPATOLOGY (2013)
Amphiregulin Enhances Regulatory T Cell-Suppressive Function via the Epidermal Growth Factor Receptor
Dietmar M. W. Zaiss et al.
IMMUNITY (2013)
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Gabriela Bindea et al.
IMMUNITY (2013)
Inactivation of tumor-specific CD8+ CTLs by tumor-infiltrating tolerogenic dendritic cells
Hirotomo Harimoto et al.
IMMUNOLOGY AND CELL BIOLOGY (2013)
NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway
Chun Sun et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling Activation
Yan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells
Chia-Lin Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
Johanna Dzieran et al.
PLOS ONE (2013)
Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
Francesco Dituri et al.
PLoS One (2013)
Combination of Intratumoral Invariant Natural Killer T Cells and Interferon-Gamma Is Associated with Prognosis of Hepatocellular Carcinoma after Curative Resection
Yong-Sheng Xiao et al.
PLOS ONE (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis
Yanli Pang et al.
CANCER DISCOVERY (2013)
Immunological efects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
James P. Stevenson et al.
ONCOIMMUNOLOGY (2013)
TGF-β in progression of liver disease
Steven Dooley et al.
CELL AND TISSUE RESEARCH (2012)
Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions
J. Luis Espinoza et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: A crucial role of CD25-FOXP3-T cells
Naruyasu Kakita et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Engineering and Therapeutic Application of Single-Chain Bivalent TGF-β Family Traps
John C. Zwaagstra et al.
MOLECULAR CANCER THERAPEUTICS (2012)
The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-β and suppresses TH2 differentiation
Makoto Kuwahara et al.
NATURE IMMUNOLOGY (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular Carcinoma
Elisabetta Cariani et al.
PLOS ONE (2012)
NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development
Patricia Sancho et al.
PLOS ONE (2012)
Cancer-related inflammation: Common themes and therapeutic opportunities
Frances R. Balkwill et al.
SEMINARS IN CANCER BIOLOGY (2012)
Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells
Laia Caja et al.
JOURNAL OF HEPATOLOGY (2011)
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Jeffrey L. Barnes et al.
KIDNEY INTERNATIONAL (2011)
Anti-Transforming Growth Factor β Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone
Swati Biswas et al.
PLOS ONE (2011)
Anti-Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
Zhaojing Zhong et al.
CLINICAL CANCER RESEARCH (2010)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor-β Monoclonal Antibody
Masaki Terabe et al.
CLINICAL CANCER RESEARCH (2009)
Cell-Intrinsic Transforming Growth Factor-β Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence In Vivo
Roberto Tinoco et al.
IMMUNITY (2009)
iNKT cell development is orchestrated by different branches of TGF-β signaling
Jean-Marc Doisne et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
An anti-transforming growth factor β antibody suppresses metastasis via cooperative effects on multiple cell compartments
Jeong-Seok Nam et al.
CANCER RESEARCH (2008)
Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice
Lorea Bueno et al.
EUROPEAN JOURNAL OF CANCER (2008)
Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
Cedric Coulouarn et al.
HEPATOLOGY (2008)
Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity
Irene Carmona-Cuenca et al.
JOURNAL OF HEPATOLOGY (2008)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF-β dependent fashion
M. Mikula et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes
J. Gotzmann et al.
ONCOGENE (2006)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma
G Giannelli et al.
GASTROENTEROLOGY (2005)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
TGF-β1 uses distinct mechanisms to inhibit IFN-γ expression in CD4+ T cells at priming and at recall:: Differential involvement of Stat4 and T-bet
JT Lin et al.
JOURNAL OF IMMUNOLOGY (2005)
p21Cip1 and p27Kip1 act in synergy to alter the sensitivity of naive T cells to TGF-β-mediated G1 arrest through modulation of IL-2 responsiveness
LA Wolfraim et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytokine traps: multi-component, high-affinity blockers of cytokine action
AN Economides et al.
NATURE MEDICINE (2003)
DLPC decreases TGF-β1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells
Q Cao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Antigen-bearing immature dendritic cells induce peptide-specific CD8+ regulatory T cells in vivo in humans
MV Dhodapkar et al.
BLOOD (2002)
Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation
L Gorelik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor β in rat fetal hepatocytes
B Herrera et al.
HEPATOLOGY (2001)
Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor β in fetal hepatocytes
B Herrera et al.
FASEB JOURNAL (2001)
Inhibition of the Na+/H+ exchanger reduces rat hepatic stellate cell activity and liver fibrosis:: An in vitro and in vivo study
A Benedetti et al.
GASTROENTEROLOGY (2001)
Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts
S Dooley et al.
HEPATOLOGY (2000)
Hepatic stellate cells: a target for the treatment of liver fibrosis
J Wu et al.
JOURNAL OF GASTROENTEROLOGY (2000)
Share Paper
